Previous close | 33.06 |
Open | 33.34 |
Bid | 32.50 x 800 |
Ask | 33.00 x 3200 |
Day's range | 32.56 - 33.35 |
52-week range | 25.77 - 40.28 |
Volume | |
Avg. volume | 1,935,700 |
Market cap | 4.444B |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.10 (3.37%) |
Ex-dividend date | 31 May 2024 |
1y target est | N/A |
Perrigo's (PRGO) new products and products added through acquisitions are expected to have aided the top line in the soon-to-be-reported quarter.
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The portfolio had a 5.7% gain in the first quarter compared to an 8.2% return in the Russell Midcap Value Index. The Strategy underperformed in Financials and Industrials due […]
Pharma company Perrigo plans to spread the word about Opill at the WNBA draft.